Conder G A, Thompson D P, Johnson S S
Animal Health Therapeutics, Upjohn Laboratories, Kalamazoo, Michigan 49001.
Vet Rec. 1993 Jun 26;132(26):651-2. doi: 10.1136/vr.132.26.651.
Studies were conducted to determine whether organisms which are resistant to ivermectin are also resistant to moxidectin. The mechanisms of action of moxidectin and ivermectin were compared by measuring the changes in membrane conductance they induced in leg muscle fibres of the common shore crab (Pachygrapsus crassipes) by using standard micro-electrode techniques. Meriones unguiculatus (jirds) were infected with ivermectin-resistant or -susceptible strains of Haemonchus contortus, treated with moxidectin or ivermectin at a dose which routinely clears more than 98 per cent of the susceptible strain, and examined for parasite clearance. The results showed that moxidectin induced a rapid loss of membrane resistance in the muscle preparation, and that the effect was almost 50 per cent reversible with the chloride channel-blocker picrotoxinin; this pattern of activity is qualitatively similar to that of ivermectin. In the jird model, moxidectin achieved a clearance of only < or = 47.2 per cent against ivermectin-resistant H contortus at a dose which invariably clears > or = 98 per cent of an ivermectin-susceptible strain. These results indicate that moxidectin and ivermectin share a common mechanism of action, and that organisms that are resistant to ivermectin are also likely to be resistant to moxidectin.
开展了多项研究以确定对伊维菌素耐药的生物是否也对莫昔克丁耐药。通过使用标准微电极技术测量它们在普通滨蟹(厚纹蟹)腿部肌肉纤维中诱导的膜电导变化,比较了莫昔克丁和伊维菌素的作用机制。用对伊维菌素耐药或敏感的捻转血矛线虫菌株感染长爪沙鼠,以通常能清除超过98%敏感菌株的剂量用莫昔克丁或伊维菌素进行治疗,并检查寄生虫清除情况。结果表明,莫昔克丁在肌肉制剂中诱导膜电阻迅速丧失,并且用氯离子通道阻滞剂印防己毒素处理后,这种效应几乎有50%是可逆的;这种活性模式在质量上与伊维菌素相似。在长爪沙鼠模型中,以能始终清除≥98%伊维菌素敏感菌株的剂量,莫昔克丁对伊维菌素耐药的捻转血矛线虫的清除率仅≤47.2%。这些结果表明,莫昔克丁和伊维菌素具有共同的作用机制,并且对伊维菌素耐药的生物也可能对莫昔克丁耐药。